XPC and cholangiocarcinoma: Our findings provide further support for the notion that SNPs in DNA repair genes, particularly in the XPC and PARP1 genes, may serve as prognostic biomarkers for patients with CCA, and highlight the importance of the DNA repair pathways in modulating tumour biology after surgical resection.